adenosine monophosphate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andres, M; Barbani, MT; Hirzel, C; Holbro, A; Ramette, A; Schenker, C; Suter-Riniker, F; Tritschler, T; Walti, LN; Zeerleder, SS | 1 |
| Helleberg, M; Kirk, O; Lane, C; Lebech, AM; Lundgren, J; Moestrup, KS; Niemann, CU | 1 |
| Altenbach, HJ; Gäb, S; Oscier, D; Podeschwa, MA; Schellenträger, M; Schmitz, OJ; Schumann, CA; Vom Brocke, J; Wirtz, M | 1 |
| Bela Agostinho, A; Francini, G; Leoncini, R; Marinello, E; Petrioli, R; Pizzichini, M; Rosi, F; Vannoni, D | 1 |
| Albertioni, F; Eriksson, S; Juliusson, G; Liliemark, J; Lindemalm, S; Pettersson, B; Reichelova, V | 1 |
| Carlucci, F; Marinello, E; Pagani, R; Tabucchi, A | 1 |
| Conigrave, AD; Fernando, KC; Gu, B; Luttrell, BM; Tasevski, V; Wiley, JS; Zhang, W | 1 |
| Carlucci, F; Marinello, E; Rosi, F; Tabucchi, A | 1 |
1 trial(s) available for adenosine monophosphate and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Drug Administration Schedule; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Metabolic Clearance Rate; Middle Aged; Regression Analysis | 1998 |
7 other study(ies) available for adenosine monophosphate and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response.
Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Immunization, Passive; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; SARS-CoV-2 | 2022 |
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Fever; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Time Factors; Treatment Outcome | 2020 |
Capillary electrophoresis-laser induced fluorescence analysis of endogenous damage in mitochondrial and genomic DNA.
Topics: 5-Methylcytosine; Adenosine Monophosphate; Animals; Biomarkers; Cattle; Chromatography, Micellar Electrokinetic Capillary; DNA Adducts; DNA Damage; DNA Methylation; DNA, Mitochondrial; Electrophoresis, Capillary; Genome; Humans; Lasers; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Oxidative Stress; Spectrometry, Fluorescence | 2005 |
Ecto 5'-nucleotidase in B-cell lymphocytic leukemia.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; B-Lymphocytes; Cytosol; Humans; Inosine Monophosphate; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Reference Values; Substrate Specificity; T-Lymphocytes | 1996 |
Synthesis of adenine and guanine nucleotides at the 'inosinic branch point' in lymphocytes of leukemia patients.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Aged; Carbon Radioisotopes; Cells, Cultured; Guanine Nucleotides; Guanosine Monophosphate; Humans; Inosine Monophosphate; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Middle Aged; Time Factors | 1999 |
P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Cyclic AMP; Dose-Response Relationship, Drug; Gene Expression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger | 2001 |
Purine nucleotide metabolism in chronic lymphocytic leukemia lymphocytes.
Topics: Adenosine Monophosphate; Aged; Humans; Inosine Monophosphate; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Middle Aged; NAD; Purine Nucleotides | 2000 |